yohimbine has been researched along with Depressive Disorder, Major in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 3 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deuter, CE; Kuehl, LK; Nowacki, J; Otte, C; Ueberrueck, L; Wingenfeld, K | 1 |
| Deuter, CE; Hellmann-Regen, J; Kaczmarczyk, M; Kuehl, LK; Otte, C; Wingenfeld, K | 1 |
| Breden, IH; Deuter, CE; Kuehl, LK; Otte, C; Schulz, A; Vögele, C; Wingenfeld, K | 1 |
| Kuehl, LK; Kuffel, A; Löwe, B; Otte, C; Schreiner, J; Spitzer, C; Terfehr, K; Uhlmann, C; Wingenfeld, K | 1 |
| Berman, RM; Cappiello, A; Charney, DS; Fasula, D; Gueorguieva, R; Kugaya, A; Liu, N; Oren, DA; Sanacora, G | 1 |
| Griffith, JM; Gurguis, GN; Rush, AJ; Vo, SP | 1 |
2 trial(s) available for yohimbine and Depressive Disorder, Major
| Article | Year |
|---|---|
Effects of noradrenergic stimulation on memory in patients with major depressive disorder.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Blood Pressure; Cross-Over Studies; Depressive Disorder, Major; Double-Blind Method; Female; Humans; Male; Memory; Salivary alpha-Amylases; Yohimbine | 2013 |
Addition of the alpha2-antagonist yohimbine to fluoxetine: effects on rate of antidepressant response.
Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Middle Aged; Personality Inventory; Psychiatric Status Rating Scales; Treatment Outcome; Yohimbine | 2004 |
4 other study(ies) available for yohimbine and Depressive Disorder, Major
| Article | Year |
|---|---|
Attentional bias in individuals with depression and adverse childhood experiences: influence of the noradrenergic system?
Topics: Attentional Bias; Depression; Depressive Disorder, Major; Humans; Norepinephrine; Yohimbine | 2021 |
Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences.
Topics: Adrenergic alpha-2 Receptor Antagonists; Adult; Adverse Childhood Experiences; alpha-Amylases; Child; Conditioning, Psychological; Cross-Sectional Studies; Depressive Disorder, Major; Fear; Female; Humans; Male; Middle Aged; Norepinephrine; Photic Stimulation; Yohimbine | 2020 |
Noradrenergic activation induced by yohimbine decreases interoceptive accuracy in healthy individuals with childhood adversity.
Topics: Adverse Childhood Experiences; Depressive Disorder, Major; Humans; Interoception; Receptors, Adrenergic; Yohimbine | 2022 |
Platelet alpha2A-adrenoceptor function in major depression: Gi coupling, effects of imipramine and relationship to treatment outcome.
Topics: Adrenergic Uptake Inhibitors; Adult; Antidepressive Agents, Tricyclic; Biomarkers; Blood Platelets; Case-Control Studies; Depressive Disorder, Major; GTP-Binding Protein alpha Subunits, Gi-Go; Humans; Imipramine; Male; Middle Aged; Norepinephrine; Protein Binding; Protein Kinases; Psychiatric Status Rating Scales; Receptors, Adrenergic, alpha-2; Treatment Outcome; Yohimbine | 1999 |